Performance of a PLK1‐based immune risk model for prognosis and treatment response prediction in breast cancer

Performance of a PLK1‐based immune risk model for prognosis and treatment response prediction in breast cancer

Abstract Objective Polo‐like kinase 1 (PLK1), a serine/threonine‐protein kinase, functions as a potent oncogene in the initiation and progression of tumor. The aim of this study is to assess potential correlations between PLK1 expression and immune infiltration in breast cancer (BRCA) and construct...

Full description

Bibliographic Details
Main Authors: Yan Chen, Yiqing You, Qiaoling Wu, Jing Wu, Shujing Lin, Yang Sun, Zhaolei Cui
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Cancer Medicine
Subjects:
breast cancer (BRCA)
immune infiltration
polo‐like kinase 1 (PLK1)
prognosis
risk model
Online Access:https://doi.org/10.1002/cam4.5813

Internet

https://doi.org/10.1002/cam4.5813

Similar Items